Edgar Lescure
Family · Arlington, TXNPI 1902452576
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 112 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 23.0% — the pattern of someone who eats at a lot of different presentations.
Across 112 payments — averaging $16.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Esperion Therapeutics, Inc.$419
- AbbVie$211
- Bayer$200
- Amgen$150
- Johnson & Johnson$143
- Boehringer Ingelheim$128
- plus $573 from 16 others
What the payments were for
- Food & beverage$1,823100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Esperion Therapeutics, Inc. | 19 | $419 |
| AbbVie | 18 | $211 |
| Bayer | 6 | $200 |
| Amgen | 20 | $150 |
| Johnson & Johnson | 4 | $143 |
| Boehringer Ingelheim | 6 | $128 |
| Novo Nordisk | 6 | $92 |
| Lilly USA, LLC | 6 | $86 |
| Eisai Inc. | 5 | $75 |
| Genentech USA, Inc. | 6 | $72 |
| Amarin Pharma, Inc. | 3 | $61 |
| Sanofi-aventis U.S. LLC | 3 | $43 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $18 |
| Redhill Biopharma Inc. | 1 | $18 |
| Pfizer | 1 | $17 |
| Merck | 1 | $15 |
| Optinose US, Inc. | 1 | $15 |
| Biohaven Pharmaceuticals, Inc. | 1 | $14 |
| AstraZeneca | 1 | $13 |
| Arbor Pharmaceuticals, Inc. | 1 | $11 |
| E.r. Squibb & Sons, L.L.C. | 1 | $11 |
| Kowa Pharmaceuticals America, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerendia$125
How this compares
$1,823 in reported general payments places this provider in the 80th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 93 | $2,789 |
| Atorvastatin Calcium | 258 | $2,179 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 12 | $2,059 |
| Gabapentin | 140 | $1,945 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 11 | $1,599 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 54 | $1,368 |
| Losartan Potassium | 133 | $1,178 |
| Levothyroxine Sodium | 131 | $1,045 |
| Hydroxyzine Hcl | 19 | $949 |
| Dutasteride | 14 | $893 |
| Doxepin Hcl | 11 | $882 |
| Tamsulosin Hcl | 57 | $869 |
| Metformin Hcl | 148 | $700 |
| Pravastatin Sodium | 51 | $660 |
| Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide | 52 | $654 |
Paid to pharmacies, not to this prescriber.
Other family in Arlington
- Nadia WinstonArlington$32K
- David WeirDallas$959K
- Robin BeachHouston$428K
- April LopezMcAllen$417K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
- Jill CampbellShenandoah$182K
- Angela AchaPflugerville$174K
- Susan BowlinIrving$164K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.